TCI Wealth Advisors’s Eupraxia Pharmaceuticals EPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding EPRX
TCI Wealth Advisors's EPRX Position: Q3 2026 in Review
TCI Wealth Advisors held its Eupraxia Pharmaceuticals (EPRX) position steady in Q3 2026 at 11,000 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #282.
TCI Wealth Advisors first reported a position in EPRX in Q3 2025 and has held it in 5 quarters since. 70 funds tracked by Wall St. Rank hold EPRX as of Q3 2026.
- TCI Wealth Advisors held 11,000 shares of Eupraxia Pharmaceuticals worth $100K as of Q3 2026.
- TCI Wealth Advisors left its Eupraxia Pharmaceuticals share count unchanged in Q3 2026.
- Eupraxia Pharmaceuticals made up ﹤0.01% of TCI Wealth Advisors's portfolio in Q3 2026, its #282 holding.
- TCI Wealth Advisors first reported a position in Eupraxia Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- 70 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q3 2026.
Based on TCI Wealth Advisors's 13F filing for Q3 2026, filed 30 Oct 2026.